Radical pleurectomy and chemoradiation for malignant pleural mesothelioma: The outcome of incomplete resections

Lung Cancer

Volumn 81, Issue 2, 2013, Pages 241-246

  Bölükbas, Servet ^a   Eberlein, Michael ^b   Fisseler Eckhoff, Annette ^a   Schirren, Joachim ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

Extrapleural pneumonectomy; Incomplete resection; Malignant pleural mesothelioma; Multimodality treatment; Pleurectomy; Prognostic factor

Indexed keywords

CARBOPLATIN;

AGED; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CHEMORADIOTHERAPY; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LUNG FUNCTION TEST; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OVERALL SURVIVAL; PLEURA EFFUSION; PLEURA MESOTHELIOMA; PLEURECTOMY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; SURGICAL MORTALITY; TUMOR GROWTH;

EXTRAPLEURAL PNEUMONECTOMY; INCOMPLETE RESECTION; MALIGNANT PLEURAL MESOTHELIOMA; MULTIMODALITY TREATMENT; PLEURECTOMY; PROGNOSTIC FACTOR;

AGED; CHEMORADIOTHERAPY; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MESOTHELIOMA; PLEURAL NEOPLASMS; PNEUMONECTOMY; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; THORACIC SURGICAL PROCEDURES; TREATMENT OUTCOME;

EID: 84879890063     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2013.04.019     Document Type: Article

References (28)

1. Sugarbaker D.J. Macroscopic complete resection: the goal of primary surgery in multimodality therapy for pleural mesothelioma. J Thorac Oncol 2006, 1:175-176.
2. Bölükbas S., Manegold C., Eberlein M., Bergmann T., Fisseler-Eckhoff A., Schirren J. Trimodality therapy for malignant pleural mesothelioma: radical pleurectomy, chemotherapy with cisplatin/pemetrexed and radiotherapy. Lung Cancer 2011, 71:75-81.
3. Rice D., Rusch V., Pass H., Asamura H., Nakano T., Edwards J., et al. Recommendations for uniform definitions of surgical techniques for malignant pleural mesothelioma: a consensus report of the international association for the study of lung cancer international staging committee and the international mesothelioma interest group. J Thorac Oncol 2011, 6(August (8)):1304-1312.
4. Bölükbas S., Eberlein M., Schirren J. Video-atlas of radical pleurectomy for malignant pleural mesothelioma. Ann Cardiothorac Surg 2012, 1(4):534-536. 10.3978/j.issn.2225-319X.2012.10.06.
5. International Union Against Cancer (UICC) TNM classification of malignant tumours 2002, Wiley-Liss, New York. 6th ed.
6. Brunelli A., Charloux A., Bolliger C.T., Rocco G., Sculier J.-P., Varela G., et al. The European Respiratory Society and European Society of Thoracic Surgeons clinical guidelines for evaluating fitness for radical treatment (surgery and chemoradiotherapy) in patients with lung cancer. Eur J Cardiothorac Surg 2009, 36:181-184.
7. de Perrot M., Uy K., Anraku M., Tsao M.S., Darling G., Waddell T.K., et al. Impact of lymph node metastasis on outcome after extrapleural pneumonectomy for malignant pleural mesothelioma. J Thorac Cardiovasc Surg 2007, 133:111-116.
8. Weder W., Stahel R.A., Bernhard J., Bodis S., Vogt P., Ballabeni P., et al. Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma. Ann Oncol 2007, 18:1196-1202.
9. Flores R.M., Pass H.I., Seshan V.E., Dycoco J., Zakowski M., Carbone M., et al. Extrapleural pneumonectomy versus pleurectomy in the surgical management of malignant pleural mesothelioma: results in 663 patients. J Thorac Cardiovasc Surg 2008, 135:620-626.
10. Lang-Lazdunski L., Bille A., Lal R., Cane P., McLean E., Landau D., et al. Pleurectomy/decortication is superior to extrapleural pneumonectomy in the multimodality management of patients with malignant pleural mesothelioma. J Thorac Oncol 2012, 7(4):737-743.
11. Vogelzang N.J., Rusthoven J.J., Symanowski J., Denham C., Kaukel E., Ruffie P., et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol 2003, 21:2636-2644.
12. Rusch V.W., Giroux D., Kennedy C., Ruffini E., Cangir A.K., Rice D., et al. Initial analysis of the international association for the study of lung cancer mesothelioma database. J Thorac Oncol 2012, 7(November (11)):1631-1639.
13. Evans A.L., Gleeson F.V. Radiology in pleural disease: state of the art. Respirology 2004, 9:300-312.
14. Wang Z.J., Reddy G.P., Gotway M.B., Higgins C.B., Jablons D.M., Ramaswamy M., et al. Malignant pleural mesothelioma: evaluation with CT, MR imaging, and PET. Radiographics 2004, 24:105-119.
15. Erasmus J.J., Truong M.T., Smythe W.R., Munden R.F., Marom E.M., Rice D.C., et al. Integrated computed tomography positron emission tomography in patients with potentially resectable malignant pleural mesothelioma: staging implications. J Thorac Cardiovasc Surg 2005, 129:1364-1370.
16. Rice D.C., Steliga M.A., Stewart J., Eapen G., Jimenez C.A., Lee J.H., et al. Endoscopic ultrasound-guided fine needle aspiration for staging of malignant pleural mesothelioma. Ann Thorac Surg 2009, 88(September):862-869.
17. Sørensen J.B., Ravn J., Loft A., Brenøe J. Berthelsen AK on behalf of the Nordic Mesothelioma Group, Preoperative staging of mesothelioma by 18F-fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography fused imaging and mediastinoscopy compared to pathological findings after extrapleural pneumonectomy. Eur J Cardiothorac Surg 2008, 34:1090-1096.
18. Flores R.M., Routledge T., Seshan V.E., Dycoco J., Zakowski M., Hirth Y., et al. The impact of lymph node station on survival in 348 patients with surgically resected malignant pleural mesothelioma: implications for revision of the American Joint Committee on Cancer staging system. J Thorac Cardiovasc Surg 2008, 136:605-610.
19. Ettinger D.S., Akerley W., Borghaei H., Chang A., Cheney R.T., Chirieac L.R., et al. Malignant pleural mesothelioma. J Natl Compr Canc Netw 2012, 10(January):26-41.
20. Ried M., Potzger T., Braune N., Neu R., Zausig Y., Schalke B., et al. Cytoreductive surgery and hyperthermic intrathoracic chemotherapy perfusion for malignant pleural tumours: perioperative management and clinical experience. Eur J Cardiothorac Surg 2012, (August). 10.1093/ejcts/ezs418.
21. Friedberg J.S., Culligan M.J., Mick R., Stevenson J., Hahn S.M., Sterman D., et al. Radical pleurectomy and intraoperative photodynamic therapy for malignant pleural mesothelioma. Ann Thorac Surg 2012, 93(May):1658-1667.
22. Wolinsky J.B., Colson Y.L., Grinstaff M.W. Local drug delivery strategies for cancer treatment: gels, nanoparticles, polymeric films, rods, and wafers. J Control Release 2012, 159(April (1)):14-26.
23. Rimner A., Rosenzweig K.E. Novel radiation therapy approaches in malignant pleural mesothelioma. Ann Cardiothorac Surg 2012, 1(4):457-461. 10.3978/j.issn.2225-319X.2012.10.07.
24. Zahid I., Sharif S., Routledge T., Scarci M. Is pleurectomy and decortication superior to palliative care in the treatment of malignant pleural mesothelioma?. Interact Cardiovasc Thorac Surg. 2011, 12(May (5)):812-817.
25. Rosenzweig K.E., Zauderer M.G., Laser B., Krug L.M., Yorke E., Sima C.S., et al. Pleural intensity-modulated radiotherapy for malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys 2012, 83(July (4)):1278-1283.
26. Bölükbas S., Eberlein M., Schirren J. Prospective study on functional results after lung-sparing radical pleurectomy in the management of malignant pleural mesothelioma. J Thorac Oncol 2012, 7(May (5)):900-905.
27. Mollberg N.M., Vigneswaran Y., Kindler H.L., Warnes C., Salgia R., Husain A.N., et al. Quality of life after radical pleurectomy decortication for malignant pleural mesothelioma. Ann. Thorac. Surg 2012, 94(October):1086-1092.
28. Hiddinga B.I., van Meerbeeck J.P. Surgery in mesothelioma - where do we go after MARS?. J Thorac Oncol 2013, (February). 10.1097/JTO.0b013e31828353d7.